Best HPV Care in Kathmandu — Monitoring, Treatment & Prevention Surveillance, Wart Treatment, Vaccination & Honest Long-Term Management

What HPV Care Actually Involves

HPV care is mostly surveillance — because infection itself is not treated directly. Most HPV clears naturally within about two years; what care manages is consequence risk: persistent high-risk infection that can produce cervical cell changes, and visible low-risk disease like warts that patients want treated for comfort or cosmetic reasons.

The clinical task after a positive high-risk screen is correct surveillance: retesting at right interval, colposcopy when cell changes appear, and treatment of confirmed precancerous lesions before they progress. The clinical task for warts is removal and recurrence management — treatment clears lesions but not virus, which is why ~30%+ recur.

And clinical task for everyone is prevention: vaccination (which prevents large majority of HPV-driven disease) and honest counselling about what infection means for partners and for future.

Surveillance After a Positive Screen

After a positive high-risk result, pathway is structured surveillance: a repeat test at recommended interval (commonly ~12 months for a positive HPV with normal cytology) to see whether infection persists, and colposcopy — a magnified cervical examination — when persistence or abnormal cells appear.

Colposcopy with directed biopsy is step that identifies precancerous change (CIN grades). When confirmed, these are treated — usually by local removal — before they can progress. The surveillance intervals exist precisely to catch small fraction that progresses at stage where treatment is straightforward.

Genital Wart Treatment

Genital warts — caused by low-risk HPV types 6 and 11 — are treated by removal or destruction: cryotherapy (freezing), topical agents applied at home or in clinic, or surgical removal for larger or resistant lesions. The method is matched to number, site and patient preference.

What treatment does and does not do: it clears visible lesions but not virus — which is why ~30% or more recur in following months. Recurrence is managed, not a treatment failure; viral activity typically declines over time as immunity catches up. During treatment and while lesions are present, sexual contact with affected sites is avoided to limit transmission.

Partners & Honest Counselling

Partners of patients with HPV findings usually need no specific action — there is no routine HPV screening test for men, and for a regular partner virus has likely already been shared. Honest counselling explains this without false reassurance: HPV is nearly universal among sexually active adults; focus is on what to do (surveillance, wart treatment) rather than who gave it to whom.

Disclosure guidance is realistic: HPV is so common that most adults carry or have carried it; a diagnosis does not establish when or from whom it came — it can persist silently for years. Partner discussions are guided toward what matters — vaccination decisions, screening, and barrier use while lesions are present.

Prevention — Vaccination & Screening

HPV vaccination prevents large majority of HPV-driven disease — cervical, anal, oropharyngeal and other cancers, plus genital warts. It is most effective before exposure (ideally adolescence) but offers benefit for many adults depending on prior exposure — eligibility is assessed honestly.

Screening continues regardless: vaccination reduces but does not eliminate risk, and cervical surveillance intervals continue for vaccinated women. Barrier protection reduces but does not eliminate transmission — HPV spreads skin-to-skin beyond what barriers cover.

HPV Care & Costs

Transparent pricing; confirm when booking.

Related Services & Guides